Structure Therapeutics Inc.
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| – | – | – | – | – | – | |
| – | +213.0% | +284.7% | +6.5% | +236.3% | +34.4% | |
| – | +160.9% | +69.1% | +225.8% | +129.4% | +54.3% | |
| – | +173.7% | +14.5% | – | – | – | |
| – | +329.4% | -26.9% | +134.7% | -57.5% | -3,078.2% | |
| – | +6,247.4% | -87.1% | +1,298.1% | -40.5% | +180.2% | |
| – | – | -447.8% | +332.1% | +33.8% | – | |
| – | – | – | – | – | – | |
| – | +299.6% | -71.9% | +1,456.3% | +14.1% | +48.0% | |
| – | – | -189.1% | – | -61.7% | +1,486.5% | |
| – | – | – | – | – | – |
Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.